Longevity Supplement
Effectiveness moderate due to evidence-based doses for some (Rhodiola 300mg matches 26-RCT meta; Mg 304mg meets RDA/ISSN) but weak longevity-specific RCTs (e.g., Fisetin 100mg vs 20mg/kg senolytic protocol; Ca-AKG only 1 RCT). Supported by product RCT on aging biomarkers. Safety excellent with GRAS status, no AEs in CAERS/652+ Mg trials. Quality good with COAs but lacks gold-standard NSF/USP certs; transparent sourcing partial. Overall balanced for multi-ingredient longevity supp.
NOVOS Core offers a convenient multi-ingredient longevity formula with a supporting product RCT on vascular aging biomarkers and mostly evidence-based doses. While individual longevity RCTs are limited for most ingredients, safety is excellent with no FDA issues. Good option lacking top certifications.